FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PUSKAS, F.
Right arrow Articles by PERL, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PUSKAS, F.
Right arrow Articles by PERL, A.
(The FASEB Journal. 2000;14:1352-1361.)
© 2000 FASEB

Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C

FERENC PUSKAS*, PETER GERGELY, JR*, KATALIN BANKI*,{dagger} and ANDRAS PERL*,{ddagger}1

* Departments of Medicine,
{dagger} Pathology, and
{ddagger} Microbiology and Immunology, State University of New York Health Science Center, College of Medicine, Syracuse, New York 13210, USA

1Correspondence: SUNY HSC, 750 East Adams Street, Syracuse, NY 13210, USA. E-mail:perla{at}upstate.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Ascorbic acid, or vitamin C, generally functions as an antioxidant by directly reacting with reactive oxygen intermediates and has a vital role in defenses against oxidative stress. However, ascorbic acid also has pro-oxidant properties and may cause apoptosis of lymphoid and myeloid cells. The present study shows that dehydroascorbate, the oxidized form of vitamin C, stimulates the antioxidant defenses of cells, preferentially importing dehydroascorbate over ascorbate. While 200–800 µM vitamin C caused apoptosis of Jurkat and H9 human T lymphocytes, pretreatment with 200-1000 µM dehydroascorbate stimulated activity of pentose phosphate pathway enzymes glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and transaldolase, elevated intracellular glutathione levels, and inhibited H2O2-induced changes in mitochondrial transmembrane potential and cell death. A 3.3-fold maximal glutathione elevation was observed after 48 h stimulation with 800 µM dehydroascorbate. In itself, dehydroascorbate did not affect cytosolic or mitochondrial reactive oxygen intermediate levels as monitored by flow cytometry using oxidation-sensitive fluorescent probes. The data reveal a novel mechanism for increasing glutathione levels through stimulation of the pentose phosphate pathway and identify dehydroascorbate as an antioxidant for cells susceptible to the pro-oxidant and proapoptotic properties of vitamin C.—Puskas, F., Gergely, P., Jr., Banki, K., Perl, A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C.


Key Words: DHA • transaldolase • glucose 6-phosphate dehydrogenase • GSH • apoptosis


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
ASCORBIC ACID, OR vitamin C, is important as a cofactor of several biosynthetic enzyme reactions and is widely used as an antioxidant (1 , 2) . However, vitamin C also has pro-oxidant properties and may cause apoptosis of human lymphocytes and myelogenous leukemia cell lines (3 , 4) . Under physiological conditions, vitamin C has a predominantly antioxidant role (5) . Pro-oxidant and proapoptotic effects of vitamin C may be related to hydroxylation (6) and/or formation of ascorbyl radicals (7) . Apoptosis, a form of programmed cell death (PCD), is indispensable for normal development and homeostasis within multicellular organisms (8) . Defects in PCD may underlie the etiology of neurodegenerative diseases, cancer, autoimmune diseases, and the acquired immune deficiency syndrome (9 , 10) .

Humans and other primates lack gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis, and therefore it must be provided from external sources (11) . Even in ascorbic acid-synthesizing species, the majority of cells need ascorbic acid from the outside (12) . Vitamin C is absorbed from the gastrointestinal tract in the form of ascorbic acid and circulates in the blood as ascorbate at pH of 7.4. Ascorbate and its oxidized form, dehydroascorbate (DHA), are taken up by transporters and facilitated diffusion in a cell type-specific manner (12) . DHA is the major transport form of ascorbate in blood cells, primarily via the hexose transporter GLUT-1 (13) . Within the cell, DHA is regenerated into ascorbate at the expense of reduced glutathione (GSH) (2) . However, ascorbate cannot regenerate GSH from its oxidized form, oxidized glutathione (GSSG). GSSG is reduced to GSH at the expense of NADPH, which is produced by the pentose phosphate pathway (PPP) (14) . In fact, a fundamental function of PPP is to maintain GSH in a reduced state, thereby protecting sulfhydryl groups and cellular integrity from emerging oxygen radicals.

The PPP comprises two separate, oxidative and nonoxidative, phases (14) . Reactions in the oxidative phase are irreversible, whereas all reactions of the nonoxidative phase are fully reversible. The two phases are functionally connected. The nonoxidative phase converts ribose 5-phosphate to glucose 6-phosphate for utilization by the oxidative phase, and thus indirectly contributes to generation of NADPH. Different enzymes are rate limiting in the two phases. The oxidative phase primarily depends on glucose 6-phosphate dehydrogenase (G6PD) (15) , whereas transaldolase (TAL) is the rate-limiting enzyme for the nonoxidative phase (16) . TAL (17) and G6PD (18) regulate NADPH production and thereby influence GSH levels, mitochondrial transmembrane potential ({Delta}{Psi}m), and susceptibility to apoptosis signals (17 , 19 , 20) . Unless reduced back to ascorbate, DHA is rapidly hydrolyzed into 2,3-diketo-L-gulonate and decarboxylated to L-xylonate and L-lyxonate (21) . In turn, these 5-carbon sugars can enter the nonoxidative branch of the PPP (22 , 23) .

This study provides evidence that DHA stimulates the activity of PPP enzymes TAL, G6PD, and 6-phosphogluconate dehydrogenase (6PGD), elevates intracellular GSH levels, and increases resistance of Jurkat human T cells to H2O2-induced cell death. Although the antioxidant and pro-oxidant properties of vitamin C have long been recognized, the existence of DHA at low concentrations in plant and animal cells has been regarded only as evidence of ascorbate oxidation (24 , 25) . The present data show that DHA is not merely a transport form of vitamin C. DHA stimulates the PPP and GSH levels and inhibits H2O2-induced cell death of cells susceptible to the pro-oxidant properties of vitamin C.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Cell culture and apoptosis assays
Jurkat human T cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 100 IU/ml penicillin, and 100 µg/ml gentamicin. H9 cells were cultured under similar conditions. For each experiment, ascorbic acid and dehydroascorbic acid (both from Sigma, St. Louis, Mo.) were freshly resuspended in H2O and the pH was adjusted to 7.4 with KOH. At physiological pH 7.4, ascorbic acid and dehydroascorbic acid dissociate to ascorbate and dehydroascorbate, respectively. Prior to assays, Jurkat cells were fed with fresh medium, seeded at a density of 2 x 105 cells/ml, and treated with ascorbate or DHA at concentrations between 100–800 µM. After pretreatment with DHA for 15 min to 36 h, cells were washed and cell death was induced with 100 µM H2O2. Apoptosis was monitored by observing cell shrinkage, nuclear fragmentation, and quantified by flow cytometry after concurrent staining with fluorescein-conjugated annexin V (annexin V-FITC, R & D Systems, Minneapolis, Minn.; FL-1) and propidium iodide (FL-2) as previously described (19) . Staining with phycoerythrin-conjugated annexin V (annexin V-PE, R & D Systems) was used to monitor phosphatidylserine (PS) externalization (FL-2) in parallel with measurement of reactive oxygen intermediates (ROI) levels and {Delta}{Psi}m, using dihydrorhodamine 123 (DHR), 5,6-carboxy-2',7'-dichlorofluorescein (DCF), or DiOC6 fluorescence. PS externalization was monitored with annexin V-FITC (FL-1) in parallel with measurement of ROI levels using ethidium (FL-2), as described (20) . Thus, annexin V-PE or annexin V-FITC was matched with emission spectra of potentiometric and oxidation-sensitive fluorescent probes. Specific combinations are described in each figure legend.

Flow cytometric analysis of ROI production and {Delta}{Psi}m
The production of ROIs was estimated fluorometrically using oxidation-sensitive fluorescent probes 5,6-carboxy-2',7'-dichlorofluorescein-diacetate (DCFH-DA), DHR, and hydroethidine (HE, Molecular Probes, Eugene, Oreg.) as described (17) . After apoptosis assay, cells were washed three times in 5 mM HEPES-buffered saline (HBS), pH 7.4, incubated in HBS with 0.1 µM DHR for 2 min, 1 µM DCFH-DA for 15 min, or 1 µM HE for 15 min, and samples were analyzed using a Becton Dickinson FACStar Plus flow cytometer equipped with an argon ion laser delivering 200 mW of power at 488 nm. Fluorescence emission from DCF (green) or DHR (green) was detected at a wavelength of 530 ± 30 nm. Fluorescence emission from oxidized HE, ethidium (red), was detected at a wavelength of 605 nm. Dead cells and debris were excluded from the analysis by electronic gating of forward and side scatter measurements. Whereas R123, the fluorescent product of DHR oxidation, binds selectively to the inner mitochondrial membrane, ethidium and DCF remain in the cytosol of living cells. Mitochondrial transmembrane potential ({Delta}{Psi}m) was estimated by staining with 40 nm 3,3'-dihexyloxacarbocyanine iodide (DiOC6, Molecular Probes), a cationic lipophilic dye (26 27 28) , for 15 min at 37°C in the dark before flow cytometry (excitation: 488 nm, emission: 525 nm recorded in FL-1). Fluorescence of DiOC6 is oxidation independent and correlates with {Delta}{Psi}m (27) . DiOC6 staining was complete after a 15 min incubation. DiOC6 fluorescence was diminished 3- to 4-fold by 5 µM mClCCP and 10-fold or more by 50 µM mClCCP, as described (20) . {Delta}{Psi}m was also quantitated using a potential-dependent, J aggregate-forming lipophilic cation, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine iodide (JC-1) (29) . JC-1 selectively incorporates into mitochondria, where it forms monomers (fluorescence in green, 527 nm) or aggregates at high transmembrane potentials (fluorescence in red, 590 nm) (29 , 30) . Cells were incubated with 1 µM JC-1 for 15 min at 37°C before flow cytometry. Cotreatment with a protonophore, 5 µM carbonyl cyanide m-chlorophenylhydrazone (mClCCP, Sigma) for 15 min at 37°C resulted in decreased DHR, DiOC6, and JC-1 fluorescence and served as a positive control for disruption of mitochondrial transmembrane potential (20) .

Pentose phosphate pathway enzyme activities
TAL activity was tested in the presence of 3.2 mM D-fructose 6-phosphate, 0.2 mM erythrose 4-phosphate, 0.1 mM NADH, 10 µg {alpha}-glycerophosphate dehydrogenase/triosephosphate isomerase at a 1:6 ratio at room temperature by continuous absorbance reading at 340 nm for 6 min (31) . The enzyme assays were conducted in the activity range of 0.001–0.01 U/ml. G6PD was measured in the presence of 120 mM Tris pH 7.7, 10 mM MgCl2, 2 mM glucose 6-phosphate, 0.9 mM NADP, and 0.1 U/ml 6PGD (32) . 6PGD activity was determined in 120 mM Tris pH 7.7, 10 mM MgCl2, 0.9 mM NADP, 2 mM 6-phosphogluconate (32) .

Glutathione levels
Total glutathione content was determined by the enzymatic recycling procedure essentially, as described by Tietze (33) . 106 cells were resuspended in 50 µl of 4.5% 5-sulfosalicylic acid. The acid-precipitated protein was pelleted by centrifugation at 4°C for 10 min at 15,000 g. The total protein content of each sample was determined using the Lowry assay (34) . GSH content of the aliquot assayed was determined in comparison to reference curves generated with known amounts of GSH (17) . GSH and GSSG were measured by reverse phase ion exchange high-performance liquid chromatography (HPLC) using UV detection at 365 nm (35) . Briefly, 106 cells were deproteinized in the presence of 10% perchloric acid and 1 mM bathophenanthroline disulfonic acid. After repeated freezing and thawing, samples were centrifuged at 15,000 g for 3 min. Fifty microliters of 100 mM mono-iodo-acetic acid in 0.2 mM m-cresol purple was added to 500 µl supernatant. Samples were neutralized by addition of 480 µl of 2 M KOH and 2.4 M KHCO3 and incubated in the dark at room temperature for 10 min. Then 1 ml of 1% fluoro-dinitro-benzene was added and the samples were incubated in the dark at 4°C overnight. After centrifugation and filtering, 100 µl of supernatants were injected into the HPLC equipped with a photodiode array detector (Waters Alliance System, Milford, Mass.) and a Waters Spherisorb NH2 column (4.6x250 mm; 10 µm) .

Measurement of ascorbate
4 x 106 Jurkat cells were treated with 400–800 µM DHA for 15 min to 48 h. After incubation, cells were washed with phosphate-buffered saline and the pellets were deproteinized in 5% metaphosphoric acid. The lysate were centrifuged for 10 min at 14,000 g; 25 µl of each supernatant was injected on a C18 column (Waters Nova-Pak; 3.9x150 mm, 4 µm). Ascorbate was detected at 232 nm wavelength using HPLC (36) .

Western blot analysis
Forty micrograms of total cell lysate in 10 µl per well was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroblotted to nitrocellulose, as described (17) . Nitrocellulose strips were incubated in 100 mM Tris pH 7.5, 0.9% NaCl, 0.1% Tween 20, and 5% skim milk with the primary antibodies, anti-G6PD rabbit antibody (37) (kindly provided by Rolf Kletzien, Upjohn, Kalamazoo, Mich.) and anti-actin monoclonal antibody C4 (Boehringer, Indianapolis, Ind.), at room temperature overnight. After washing, the blots were incubated with biotinylated secondary antibodies and then with horseradish peroxidase-conjugated avidin (Jackson Laboratories, West Grove, Pa.). In between incubations, the strips were washed in 0.1% Tween-20, 100 mM Tris pH 7.5, and 0.9% NaCl. The blots were developed with a substrate comprised of 1 mg/ml 4-chloronaphthol and 0.003% hydrogen peroxide. G6PD and actin protein levels of control and DHA-treated cells were quantified by densitometry (Model GS-700, Bio-Rad, Hercules, Calif.) of Western blots.

Statistics
Alterations in cell survival, PPP enzyme activities, and GSH levels were analyzed by Student’s t test. Changes were considered significant at P<0.05.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Ascorbic acid induces apoptosis of lymphoid and myeloid cells at concentrations above the normal serum level of 50 µM (3 , 4 , 7) . Accordingly, incubation of Jurkat human T cells with 200–800 µM ascorbic acid dose-dependently diminished cell survival (Fig. 1A ). Since lymphoid cells preferentially import DHA, the oxidized form of ascorbic acid, we examined the effect of DHA on cell survival and intracellular accumulation of ascorbate. Treatment with DHA, up to 1 mM, did not influence cell viability (Fig. 1B ). Fifteen minutes after addition of DHA (400 µM), intracellular ascorbate levels increased from 2.72 ± 0.05 mM to 4.54 ± 0.01 mM (mean±SD of four experiments; P<0.001). Ascorbate levels were also elevated after 60 min DHA treatment (4.60±0.01 mM) and returned to baseline 48 h after addition of DHA. Subsequently, we examined the effect of DHA on H2O2-induced apoptosis. Jurkat cells were preincubated with DHA, washed, and apoptosis was induced with 100 µM H2O2, as described before (17) . Surprisingly, short- (20 min to 2 h) and long-term (24 h to 48 h) DHA pretreatment had opposing effects on cell survival. Preincubation with DHA for 20 min to 2 h enhanced H2O2-induced apoptosis (Figs. 1B, C ). In contrast, pretreatment with DHA for 36 h strongly inhibited cell death (Fig. 1B, C ). When Jurkat cells were pretreated with DHA for 36 h, washed, and repeatedly preincubated with DHA for 1 h, H2O2-induced apoptosis was reduced (Fig. 1C ). These studies suggest that the effect of long-term pretreatment was dominant over short-term effects of DHA. Similar findings were obtained in H9 human T cells (data not shown).



View larger version (30K):
[in this window]
[in a new window]
 
Figure 1. Effects of ascorbate and dehydroascorbate (DHA) on cell survival. A) Toxicity of ascorbate. Jurkat cells were cultured in the absence or presence of 200 to 800 µM ascorbate for 48 h and viability was assessed by trypan blue staining. B) Effect of DHA pretreatment on H2O2 induced cell death. Jurkat cells were preincubated in the presence or absence of 400 µM DHA for 0.3–36 h. Cells were washed, stimulated with 100 µM H2O2 for 24 h, and % survival was quantified by trypan blue exclusion. Data represent mean ± SE of three independent experiments. C) Time course of H2O2-induced cell death after pretreatment with DHA. Cells were preincubated with 400 µM DHA for 1 h, 36 h, or 36 h + 1 h, washed, and exposed to 100 µM H2O2. Cell survival was quantified by trypan blue exclusion. Data represent mean ± SE of four or more independent experiments. *P<0.05; **P<0.01; ***P<0.001.

The mechanism of action of DHA on H2O2-induced apoptosis was likely to involve GSH metabolism (2) . Short-term (less than 8 h) incubation with DHA had no effect on GSH levels, whereas pretreatment with DHA for 24 h to 48 h increased intracellular GSH levels up to threefold (Fig. 2A ). Maximum GSH elevation, from a baseline of 7.65 ± 1.2 ng/ml to 25.36 ± 3.05 ng/ml (P<0.001), was observed after 48 h stimulation with 800 µM DHA (Fig. 2A ). Five-carbon products of DHA catabolism can enter the PPP (23) . Previous studies revealed that activity of PPP enzymes TAL (17) and G6PD influence GSH levels and sensitivity to apoptosis dependent on formation of ROIs (18) . Therefore, the effect of DHA on these enzyme activities was also evaluated. G6PD, 6PGD, and TAL activities were increased after incubation with DHA in a time- (Fig. 2A ) and concentration-dependent manner (Fig. 2B ). G6PD activity started to rise 24 h after addition of DHA. Incubation with 800 µM DHA doubled G6PD activity after 48 h (Fig. 2A ). This was accompanied by a 5.9-fold increase in G6PD protein levels with respect to actin levels based on densitometry of Western blots (Fig. 2C ). 6PGD and TAL activities were stimulated to a lesser extent (Fig. 2A, B ). Since DHA can be reduced back to ascorbate at the expense of GSH, we studied the time course of DHA-induced changes in GSH and GSSG levels. Preincubation with DHA for less than 24 h did not influence intracellular GSH or GSSG levels or PPP enzyme activities (Fig. 2A, D ). HPLC measurement of GSH and GSSG levels after 48 h of preincubation with DHA showed a selective increase of GSH levels (Fig. 2D ). This indicated that augmented PPP activities after long-term DHA pretreatment were not triggered by an initial GSH oxidation, i.e., depletion of GSH or increased GSSG content.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 2. Effect of DHA on intracellular GSH content and PPP enzyme activities. A) Time course of DHA-induced changes. GSH levels were measured with the enzymatic recycling method. Jurkat cells were preincubated with 800 µM DHA for the indicated time intervals displayed on the x axis (log scale). GSH content (ng/g protein) and activity of PPP enzymes G6PD, 6PGD, and TAL (mU/g protein) are shown on the y axis (linear scale). B) Concentration dependence of DHA-induced changes on GSH levels and G6PD, 6PGD, and TAL activities. Jurkat cells were preincubated with 100–800 µM DHA for 48 h. C) Western blot analysis of G6PD expression after treatment with DHA for 48 h. Concentrations of DHA in µM is indicated above each lane. Level of G6PD expression was compared to that of actin. After pretreatment with 800 µM DHA, densitometry showed a 5.9-fold increase of G6PD with respect to actin. D) Effect of DHA on reduced (GSH) and oxidized (GSSG) glutathione in Jurkat cells. GSH and GSSG were assessed by HPLC after preincubation with 800 µM DHA for 1 h and 48 h, respectively. Data represent the mean ± SE of 4–6 independent experiments. *P<0.05; **P<0.01; ***P<0.001.

Disruption of the mitochondrial membrane potential ({Delta}{Psi}m) has been proposed as the point of no return in apoptotic signaling (28 , 38 , 39) . Mitochondrial membrane permeability is subject to regulation by an oxidation reduction equilibrium of ROIs, pyridine nucleotides (NADH/NAD + NADPH/NADP), and GSH levels (40) . Since DHA stimulated PPP enzyme activities and augmented GSH levels, its effect on {Delta}{Psi}m was also investigated. {Delta}{Psi}m and mitochondrial ROI production were monitored with respect to externalization of PS, an early event in PCD (41 , 42) . As expected, incubation with H2O2 resulted in PS externalization (Fig. 3A, B) . {Delta}{Psi}m was diminished in annexin V-positive cells (Fig. 3A ). In correlation with previous results, DiOC6 fluorescence was increased in annexin V-negative cells (Fig. 3A ), suggesting that an elevation of {Delta}{Psi}m preceded PS externalization in Jurkat cells (19 , 20) . Control cells stained with JC-1 showed green fluorescence whereas H2O2-treated cells gained red JC-1 fluorescence (Fig. 3C ), consistent with a higher {Delta}{Psi}m (20 , 29 , 30) .




View larger version (94K):
[in this window]
[in a new window]
 
Figure 3. Effect of DHA on H2O2-induced changes in mitochondrial transmembrane potential ({Delta}{Psi}m), ROI levels, and cell death. Jurkat cells were preincubated with or without 400 µM DHA for 1 h (short-term) or 36 h (long-term pretreatment). Cells were washed, exposed to 100 µM H2O2 for 24 h, and analyzed by flow cytometry. Dead cells and debris were gated out by forward (FSC) and side (SSC) scatter measurements. A) Concurrent monitoring of PS externalization and {Delta}{Psi}m by staining with annexin V-PE (FL-2) and DiOC6 (FL-1), respectively (dot plots, left columns). Mean channel number of DiOC6 fluorescence and percentage of annexin V-PE-negative cells (in parentheses) are indicated in the upper left corner of each dot plot. H2O2 treatment increased DiOC6 fluorescence in annexin V-PE (FL2) -negative cells and decreased DiOC6 fluorescence in annexin V-PE-positive cells. H2O2-induced increase of {Delta}{Psi}m is shown by overlay of DiOC6 fluorescence of annexin V-negative populations (histograms, right columns). Shaded curves correspond to control cells, open curves represent H2O2- and/or DHA-treated cells. The x axis shows log FL-1 fluorescence intensity; y axis indicates cell number (events). Values over curves indicate mean channel of DiOC6 fluorescence. H2O2-induced augmentation of {Delta}{Psi}m and cell death was accelerated by 1 h of DHA pretreatment and inhibited by 36 h of DHA pretreatment. B) Lasting inhibition of H2O2-induced increase of {Delta}{Psi}m and cell death by 36 h DHA pretreatment. Cells were preincubated in the presence or absence of 400 µM DHA for 36 h. PS externalization and {Delta}{Psi}m were analyzed after 48 treatment with 100 µM H2O2. Mean channel number of DiOC6 fluorescence and percentage of annexin V-PE-negative cells (in parentheses) are indicated in the upper left corner of each dot plot. C) JC-1 fluorescence (FL-2) of DHA- and/or H2O2-treated (shaded histogram) and control cells (open histogram). Cells were incubated in the presence or absence of 400 µM DHA for 1 or 36 h. After washing, apoptosis was induced with 100 µM H2O2 for 24 h. FL-2 (x axis) represents JC-1 fluorescence of live cells (events, y axis) based on FSC/SSC measurements. D) Monitoring of the effect of DHA on H2O2-induced augmentation of {Delta}{Psi}m and cell death by concurrent staining with annexin V-PE (FL-2) and DHR (FL-1), respectively (dot plots, left columns). Cells were incubated in the presence or absence of 400 µM DHA for 1 or 36 h. After washing, apoptosis was induced with 100 µM H2O2 for 24 h, and cells were analyzed by flow cytometry. Mean channel number of DHR fluorescence and percentage of annexin V-PE-negative cells (in parentheses) are indicated in the upper left corner of each dot plot. H2O2 treatment increased DHR fluorescence in annexin V-PE (FL2) -negative cells and decreased DHR fluorescence in annexin V-PE-positive cells. H2O2-induced increase of {Delta}{Psi}m is shown by overlay of DHR fluorescence of annexin V-negative populations (histograms, right columns). Shaded curves correspond to control cells, open curves represent H2O2- and/or DHA-treated cells. The x axis shows log FL-1 fluorescence intensity; y axis indicates cell number (events). Values over curves indicate mean channel of DHR fluorescence./P>

DHA pretreatment for 36 h inhibited key checkpoints of H2O2-induced apoptosis, attenuated the augmentation of {Delta}{Psi}m in annexin V-negative cells (Fig. 3A ), and reduced PS externalization (Figs. 3a and 3b) . By contrast, 1 h DHA pretreatment stimulated H2O2-induced elevation of {Delta}{Psi}m in annexin V-negative cells and accelerated PS externalization (Figs. 3A, C ). One hour of DHA pretreatment increased {Delta}{Psi}m even in the absence of H2O2 (Fig. 4A, B ). This effect of DHA on {Delta}{Psi}m was not associated with increased production of ROIs (Fig. 4C, D ). The effect of DHA on ROI levels was assessed by flow cytometry using oxidation-sensitive fluorescent probes DHR and HE, as described earlier (17 , 20 , 43 , 44) . DHR is nonfluorescent, uncharged, and readily taken up by cells whereas R123, the product of DHR oxidation, is fluorescent, positively charged, and binds selectively to the inner mitochondrial membrane of living cells (44) . Fluorescence of this dye is an indicator of mitochondrial ROI production and maintenance of the membrane integrity and transmembrane potential. HE is oxidized into ethidium by ROIs and remains in the cytosol (45) . Thus, R123 fluorescence correlates with mitochondrial ROI levels whereas ethidium fluorescence reflects cytosolic ROI levels. Short-term (1 h) or long-term (36 h) treatment with DHA alone has not increased R123 (Fig. 3D ) and ethidium fluorescence (Fig. 4D ), thus excluding the possibility of an DHA-induced oxidative stress.




View larger version (79K):
[in this window]
[in a new window]
 
Figure 4. Transient increase of {Delta}{Psi}m by DHA. Jurkat cells were pretreated with 400 µM DHA for 1 h. Cells were washed, incubated with 100 µM H2O2 for 6 h, and analyzed by flow cytometry. A) PS externalization and {Delta}{Psi}m were concurrently monitored by staining with annexin V-PE (FL-2) and DiOC6 (FL-1), respectively (dot plots, left columns). Mean channel number of DiOC6 fluorescence and percentage of annexin V-PE-negative cells (in parentheses) are indicated in the upper left corner of each dot plot. DHA-induced increase of {Delta}{Psi}m is shown by overlay of DiOC6 fluorescence of annexin V-negative populations (histograms, right columns). Shaded curves correspond to control cells, open curves represent H2O2- and/or DHA-treated cells. B) Assessment of {Delta}{Psi}m by JC-1 fluorescence (FL-2) in DHA- and/or H2O2-treated (open histogram) and control cells (shaded histogram). C) Monitoring of the effect of DHA on {Delta}{Psi}m by concurrent staining with annexin V-PE (FL-2) and DHR (FL-1), respectively (dot plots, left columns). DHA and H2O2-induced increase {Delta}{Psi}m is shown by overlay of DHR fluorescence of annexin V-negative populations (histograms, right columns). Shaded curves correspond to control cells, open curves represent H2O2- and/or DHA-treated cells. D) Effect of DHA on ROI levels. PS externalization and ROI production were concurrently monitored by annexin V-FITC (FL1) and HE (FL-2) staining (dot plots, left columns). Effect of DHA and H2O2 (positive control) on ROI levels is shown by overlay of HE fluorescence of annexin V-negative populations (histograms, right columns). Shaded curves correspond to control cells, open curves represent DHA and/or H2O2-treated cells. Data are representative of four independent experiments. Continued on next page


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
A metabolic relationship between the GSH/GSSG and ascorbate/DHA redox couples has long been recognized (2) . Vitamin C functions as an antioxidant by reacting directly with ROIs or regenerating vitamin E from {alpha}-tocopheroxyl radical (1 , 46) . Thus, it protects cell membranes from external oxidants and has a GSH-sparing effect. However, vitamin C cannot be efficiently transported into blood cells. In fact, ascorbate concentrations above the normal serum level of 50 µM induce oxidative stress and apoptosis of lymphoid and myeloid cells (3 , 4 , 7) . The existence of DHA has long been considered evidence of ascorbate oxidation (24 , 25) . Blood cells and related tumor cell lines preferentially import DHA over ascorbate (12) . The present study provides evidence that DHA can increase GSH levels through stimulation of the PPP. A maximum of 3.3-fold GSH elevation was observed after 48 h stimulation with 800 µM DHA. DHA may be a more potent stimulator of GSH levels than N-acetyl cysteine. GSH levels could only be increased up to twofold by treatment with N-acetyl cysteine, at an optimal concentration of 3 mM, in Jurkat cells (17) . Thus, intracellular presence of DHA may not only represent an accumulation of the oxidized form of vitamin C, but may have a role in influencing GSH levels through the PPP. Products of DHA metabolism, 2,3-diketo-L-gulonate and its decarboxylation products, L-xylonate and L-lyxonate, can enter the nonoxidative branch of PPP (21 22 23) . Activity of the PPP is vitally important by providing NADPH for biosynthetic reactions and maintenance GSH in a reduced state and, thus, regulating the redox homeostasis of the cell. Accordingly, treatment of Jurkat cells with DHA increased G6PD, 6PGD, and TAL activities. These changes were accompanied by a severalfold increase in GSH level and protection from H2O2-induced cell death. DHA-induced elevations of enzyme activities were accompanied by a 2.6 ± 0.2-fold increase in G6PD protein levels with respect to actin levels, suggesting that DHA may stimulate gene expression. Carbon flux via the PPP has been implicated in regulating expression of other glucose-metabolizing enzymes, pyruvate kinase (47) , glucose 6-phosphatase, and phosphoenolpyruvate carboxykinase (48) . While xylulose 5-phosphate (X5P) has been proposed as a key intermediate, its effect on the PPP and potential involvement of X5P metabolites remain to be determined (47 , 48) .

GSH and GSSG levels were not affected by pretreatment of Jurkat cells with DHA for less than 24 h. Along the same line, DHA did not influence intracellular ROI levels as estimated by DHR and HE fluorescence. DHA treatment, up to 1 mM, did not affect cell viability. Our data correlate with observations by others showing that DHA has no pro-oxidant effects and it may directly neutralize ROIs by undergoing a peroxidative decarboxylation reaction (49) . Thus, the possibility that increased PPP enzyme activities were triggered by a DHA-induced oxidative stress could clearly be excluded.

Stimulation by DHA of activities of the NADPH-generating enzymes G6PD and 6PGD may be responsible for elevation of GSH levels. Genetically enforced augmentation of G6PD activities can increase GSH levels and resistance to apoptosis signals (17 18 19) . In turn, increased GSH can directly stimulate expression of {gamma}-glutamylcysteine synthetase, the rate-limiting enzyme of de novo GSSG synthesis (50) , and further support GSH production.

Pretreatment with DHA from 20 min to 2 h increased {Delta}{Psi}m and enhanced toxicity of H2O2. Short-term (< 2 h) DHA pretreatment increased {Delta}{Psi}m, even in the absence of H2O2. This effect of DHA on {Delta}{Psi}m was not associated with increased production of ROIs. Elevation of {Delta}{Psi}m, which precedes PS externalization (20) , was clearly enhanced by short-term DHA treatment. This transient effect of DHA may be related to its rapid metabolism (25) . Once transported into the cell, DHA is reduced back to ascorbate or rapidly hydrolyzed (25) . Ascorbate passively diffuses through the inner mitochondrial membrane (51) . The resultant increase in ascorbate or short-chain sugar content (52 , 53) may be responsible for the transient elevation of {Delta}{Psi}m and susceptibility to H2O2-induced cell death. Short-chain sugars, glyceraldehyde, dihydroxyacetone, erythrose (53) , and ribose 5-phosphate (52) can enhance oxidative killing (53) and cause apoptosis of lymphocytes (52) . Thus, DHA metabolism in the nonoxidative branch of the PPP may increase the concentration of short-chain sugars and temporarily enhance toxicity of H2O2. A combination of long- and short-term treatment regimens revealed an overall protective effect of DHA against cell death.

A direct redox relationship between ascorbate and glutathione has long been established (2) . This latter relationship is based on the glutathione-sparing effect of ascorbate in the event of oxidative stress (2) . The present work is reveals an indirect relationship between DHA and glutathione via the PPP. DHA can elevate GSH levels through stimulation of the PPP pathway. This antioxidant effect of DHA is clearly distinct from the previously recognized glutathione-sparing effect of ascorbate. The effect of DHA on the PPP and GSH synthesis is also significant with respect to the pro-oxidant/proapoptotic effects of ascorbate on myeloid and lymphoid cells (3 , 4) . By stimulation of GSH levels, DHA may have a important role in antioxidant defenses of cells preferentially importing DHA over ascorbate. The data identify DHA and its sugar metabolites as potential targets for development of novel therapeutics aimed at enhancing antioxidant defenses.


   ACKNOWLEDGMENTS
 
This work was supported in part by grants RO1 DK 49221 and 1FO5TW05421 from the National Institutes of Health, RG 2466A1/3 from the National Multiple Sclerosis Society, and the Central New York Community Foundation. We thank Dr. Paul Phillips for continued encouragement and support and Dr. Rolf Kletzien for anti-G6PD antibody.

Received for publication August 20, 1999. Revision received November 23, 1999.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Beyer, R. E. (1994) The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J. Bioenerg. Biomembr. 26,349-358[Medline]
  2. Meister, A. (1994) Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 269,9397-9400[Free Full Text]
  3. Podmore, I. D., Griffiths, H. R., Herbert, K. E., Mistry, N., Mistry, P., Lunec, J. (1998) Vitamin C exhibits pro-oxidant properties [letter]. Nature (London) 392,559[Medline]
  4. Amano, Y., Sakagami, H., Tanaka, T., Yamanaka, Y., Nishimoto, Y., Yamaguchi, M. (1998) Uncoupling of incorporation of ascorbic acid and apoptosis induction. Anticancer Res 18,2503-2506[Medline]
  5. Carr, A., Frei, B. (1999) Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J 13,1007-1024[Abstract/Free Full Text]
  6. Udenfriend, S., Clark, C. T., Axelrod, J., Brodie, B. B. (1954) Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation. J. Biol. Chem. 208,731-739[Free Full Text]
  7. Sakagami, H., Satoh, K. (1997) Modulating factors of radical intensity and cytotoxic activity of ascorbate (review). Anticancer Res 17,3513-3520[Medline]
  8. Wyllie, A. H., Kerr, J. F. R., Currie, A. E. (1980) Cell death: The significance of apoptosis. Int. Rev. Cytol. 68,251-306[Medline]
  9. Nagata, S., Golstein, P. (1995) The Fas death factor. Science 267,1449-1456[Abstract/Free Full Text]
  10. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267,1456-1462[Abstract/Free Full Text]
  11. Nishikimi, M., Yagi, K. (1991) Molecular basis fro the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am. J. Clin. Nutr. 54,1203S-1208S[Abstract/Free Full Text]
  12. Goldenberg, H., Schweinzer, E. (1994) Transport of vitamin c in animal and human cells. J. Bioenerg. Biomembr. 26,359-367[Medline]
  13. Vera, J. C., Rivas, C. I., Fischbarg, J., Golde, D. W. (1993) Mammalian facilitative hexose transporters mediate the transport of dehyrdoascorbic acid. Nature (London) 364,79-82[Medline]
  14. Mayes, P. (1993) The pentose phosphate pathway and other pathways of hexose metabolism. Murray, R. Granner, D. Mayes, P. Rodwell, V. eds. Harper’s Biochemistry ,201-211 Appleton & Lange Norwalk, Connecticut.
  15. Wood, T. (1985) The Pentose Phosphate Pathway Academic Press New York.
  16. Heinrich, P. C., Morris, H. P., Weber, G. (1976) Behavior of transaldolase (EC 2.2.1.2.) and transketolase (EC 2.2.1.1.) in normal neoplastic, differentiating, and regenerating liver. Cancer Res 36,3189-3197[Medline]
  17. Banki, K., Hutter, E., Colombo, E., Gonchoroff, N. J., Perl, A. (1996) Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 271,32994-33001[Abstract/Free Full Text]
  18. Salvemini, F., Franze, A., Iervolino, A., Filosa, S., Salzano, S., Ursini, M. V. (1999) Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J. Biol. Chem. 274,2750-2757[Abstract/Free Full Text]
  19. Banki, K., Hutter, E., Gonchoroff, N. J., Perl, A. (1998) Molecular ordering in HIV-induced apoptosis: oxidative stress, activation of caspases, and cell survival are regulated by transaldolase. J. Biol. Chem. 273,11944-11953[Abstract/Free Full Text]
  20. Banki, K., Hutter, E., Gonchoroff, N., Perl, A. (1999) Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J. Immunol. 162,1466-1479[Abstract/Free Full Text]
  21. Kanfer, J., Ashwell, G., Burns, J. J. (1960) Formation of L-lyxonic and L-xylonic acids from L-ascorbic acid in rat kidney. J. Biol. Chem. 235,2518-2521[Free Full Text]
  22. Braun, L., Puskas, F., Csala, M., Gyorffy, E., Garzo, T., Mandl, J., Banhegyi, G. (1996) Gluconeogenesis from ascorbic acid: ascorbate recycling in isolated murine hepatocytes. FEBS Lett 390,183-186[Medline]
  23. Banhegyi, G., Braun, L., Csala, M., Puskas, F., Mandl, J. (1997) Ascorbate metabolism and its regulation in animals. Free Rad. Biol. Med. 23,793-803[Medline]
  24. Szent-Gyorgyi, A. (1928) Observations on the function of peroxidase systems and the chemistry of the adrenal cortex. Biochem. J. 22,1387-1409
  25. Winkler, B. S., Orselli, S. M., Rex, T. S. (1994) The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Rad. Biol. Med. 17,333-349[Medline]
  26. Petit, P. X., O’Connor, J. E., Grunwald, D., Brown, S. C. (1990) Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. Eur. J. Biochem. 194,389-397[Medline]
  27. Tanner, M. K., Wellhausen, S. R., Klein, J. B. (1993) Flow cytometric analysis of altered mononuclear cell transmembrane potential induced by cyclosporin. Cytometry 14,59-69[Medline]
  28. Xiang, J., Chao, D. T., Korsmeyer, S. J. (1996) BAX-induced cell death may not require interleukin 1ß-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93,14559-14563[Abstract/Free Full Text]
  29. Smiley, S. T., Reers, M., Mottola-Hartshorn, C., lin, M., Chen, A., Smith, T. W., Steele, G. D., Jr, Chen, L. B. (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming cation JC-1. Proc. Natl. Acad. Sci. USA 88,3671-3675[Abstract/Free Full Text]
  30. Cossarizza, A., Franceschi, C., Monti, D., Salvioli, S., Bellesia, E., Rivabene, R., Biondo, L., Rainaldi, G., Tinari, A., Malorni, W. (1995) Protective effect of N-acetylcysteine in tumor necrosis factor-{alpha}-induced apoptosis in U937 cells: the role of mitochondria. Exp. Eye Res. 220,232-240
  31. Pontremoli, S., Prandini, D. B., Bonsignore, A., Horecker, B. L. (1961) The preparation of crystalline transaldolase from Candida utilis. Proc. Natl. Acad. Sci. USA 47,1942-1955[Free Full Text]
  32. Rudack, D., Chisholm, E. M., Holten, D. (1971) Rat Liver Glucose 6-phosphate dehydrogenase. J. Biol. Chem. 246,1249-1254[Abstract/Free Full Text]
  33. Tietze, F. (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27,502-522[Medline]
  34. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193,265-275[Free Full Text]
  35. Fariss, M. W., Reed, D. J. (1987) High-performance liquid chromatography of thiols and disulfides: dinitrophenol derivatives. Methods Enzymol 143,101-109[Medline]
  36. Harapanhalli, R. S., Howell, R. W., Rao, D. V. (1993) Testicular and plasma ascorbic acid levels in mice following dietary intake: high-performance liquid chromatographic analysis. J. Chromatogr. 614,233-243[Medline]
  37. Cramer, C. T., Cooke, S., Ginsberg, L. C., Kletzien, R. F., Stapleton, S. R., Ulrich, R. G. (1995) Upregulation of glucose-6-phosphate dehydrogenase in response to hepatocellular oxidative stress: studies with diquat. J. Biochem. Toxicol. 10,293-298[Medline]
  38. Susin, S. A., Zamzami, N., Castedo, M., Daugas, E., Wang, H., Geley, S., Fassy, F., Reed, R. C., Kroemer, G. (1997) The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186,25-37[Abstract/Free Full Text]
  39. Vander Heiden, M., Chandel, N. S., Williamson, E. K., Schumaker, P. T., Thompson, C. B. (1997) Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91,627-637[Medline]
  40. Constantini, P., Chernyak, B. V., Petronilli, V., Bernardi, P. (1996) Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271,6746-6751[Abstract/Free Full Text]
  41. Vermes, I., Haanen, C., Steffens-Nakken, H., Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 184,39-51[Medline]
  42. Martin, S. J., Reutelingsperger, C. P. M., McGahon, A. J., Rader, J. A., van Schie, C. A. A., LaFace, D. M., Green, D. R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and Abl. J. Exp. Med. 182,1545-1556[Abstract/Free Full Text]
  43. Burow, S., Valet, G. (1987) Flow-cytometric characterization, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2,7-dichlorofluorescein (DCF). Eur. J. Cell Biol. 43,128-133[Medline]
  44. Royall, J. A., Ischiropoulos, H. (1993) Evaluation of 2',7'-dichlorofluorescein and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch. Biochem. Biophys. 302,348-355[Medline]
  45. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., Kroemer, G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182,367-377[Abstract/Free Full Text]
  46. Parker, J. E., Slater, T. F., Wilson, R. L. (1979) Direct observation of a free radical interaction between vitamin E and vitamin C. Nature (London) 278,737-738[Medline]
  47. Doiron, B., Cuif, M., Chen, R., Kahn, A. (1996) Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J. Biol. Chem. 271,5321-5324[Abstract/Free Full Text]
  48. Massillon, D., Chen, W., Barzilai, N., Prus-Wertheimer, D., Hawkins, M., Liu, R., Taub, R., Rossetti, L. (1998) Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J. Biol. Chem. 273,228-234[Abstract/Free Full Text]
  49. Devamanoharan, P. S., Morris, S. M., Varma, S. D. (1996) Oxyradical scavenging effects of dehydroascorbate. Mol. Cell. Biochem. 156,131-134[Medline]
  50. Urata, Y., Yamamoto, H., Goto, S., Tsushima, H., Akazawa, S., Yamashita, S., Nagataki, S., Kondo, T. (1996) Long exposure to glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1ß and tumor necrosis factor-{alpha} in mouse endothelial cells. J. Biol. Chem. 271,15146-15152[Abstract/Free Full Text]
  51. Ingebretsen, O. C., Normann, P. T. (1982) Transport of ascorbate into guinea pig liver mitochondria. Biochim. Biophys. Acta 684,21-26[Medline]
  52. Barbieri, D., Grassilli, E., Monti, D., Salvioli, S., Franceschini, M. G., Franchini, A., Bellesia, E., Salomoni, P., Negro, P., Capri, M., Troiano, L., Cossarizza, A., Franceschi, C. (1994) D-ribose and deoxy D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 201,1109-1116[Medline]
  53. Benov, L., Fridovich, I. (1998) Superoxide dependence of the toxicity of short chain sugars. J. Biol. Chem. 273,25741-25744[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
M. L Rise, S. E Douglas, D. Sakhrani, J. Williams, K V. Ewart, M. Rise, W. S Davidson, B. F Koop, and R. H Devlin
Multiple microarray platforms utilized for hepatic gene expression profiling of GH transgenic coho salmon with and without ration restriction.
J. Mol. Endocrinol., October 1, 2006; 37(2): 259 - 282.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. A. Krone and J. T. A. Ely
Controlling Hyperglycemia as an Adjunct to Cancer Therapy
Integr Cancer Ther, March 1, 2005; 4(1): 25 - 31.
[Abstract] [PDF]


Home page
J. Immunol.Home page
G. Nagy, M. Barcza, N. Gonchoroff, P. E. Phillips, and A. Perl
Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells
J. Immunol., September 15, 2004; 173(6): 3676 - 3683.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Grossman, Y. Qian, K. Banki, and A. Perl
ZNF143 Mediates Basal and Tissue-specific Expression of Human Transaldolase
J. Biol. Chem., March 26, 2004; 279(13): 12190 - 12205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Petrat, S. Paluch, E. Dogruoz, P. Dorfler, M. Kirsch, H.-G. Korth, R. Sustmann, and H. de Groot
Reduction of Fe(III) Ions Complexed to Physiological Ligands by Lipoyl Dehydrogenase and Other Flavoenzymes in Vitro: IMPLICATIONS FOR AN ENZYMATIC REDUCTION OF Fe(III) IONS OF THE LABILE IRON POOL
J. Biol. Chem., November 21, 2003; 278(47): 46403 - 46413.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Nagy, A. Koncz, and A. Perl
T Cell Activation-Induced Mitochondrial Hyperpolarization Is Mediated by Ca2+- and Redox-Dependent Production of Nitric Oxide
J. Immunol., November 15, 2003; 171(10): 5188 - 5197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Gergely Jr., B. Niland, N. Gonchoroff, R. Pullmann Jr., P. E. Phillips, and A. Perl
Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus
J. Immunol., July 15, 2002; 169(2): 1092 - 1101.
[Abstract] [Full Text] [PDF]


Home page
Plant Cell PhysiolHome page
C. Paciolla, M. C. De Tullio, A. Chiappetta, A. M. Innocenti, M. B. Bitonti, R. Liso, and O. Arrigoni
Short- and Long-Term Effects of Dehydroascorbate in Lupinus albus and Allium cepa Roots
Plant Cell Physiol., August 1, 2001; 42(8): 857 - 863.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow